Art. 126a Directive (EU) 2001/83

In forcesince 20 Jan 2011cited 6×
1.

In the absence of a marketing authorisation or of a pending application for a medicinal product authorised in another Member State in accordance with this Directive, a Member State may for justified public health reasons authorise the placing on the market of the said medicinal product.

2.

When a Member State avails itself of this possibility, it shall adopt the necessary measures in order to ensure that the requirements of this Directive are complied with, in particular those referred to in Titles V, VI, VIII, IX and XI. Member States may decide that Article 63(1) and (2) shall not apply to medicinal products authorised under paragraph 1.

3.

Before granting such a marketing authorisation, a Member State:

(a)

shall notify the marketing authorisation holder, in the Member State in which the medicinal product concerned is authorised, of the proposal to grant a marketing authorisation under this Article in respect of the medicinal product concerned.

(b)

may request the competent authority in that Member State to submit copies of the assessment report referred to in Article 21(4) and of the marketing authorisation in force in respect of the medicinal product concerned. If so requested, the competent authority in that Member State shall supply, within 30 days of receipt of the request, a copy of the assessment report and the marketing authorisation in respect of the medicinal product concerned.

4.

The Commission shall set up a publicly accessible register of medicinal products authorised under paragraph 1. Member States shall notify the Commission if any medicinal product is authorised, or ceases to be authorised, under paragraph 1, including the name or corporate name and permanent address of the authorisation holder. The Commission shall amend the register of medicinal products accordingly and make this register available on their website.

5.

No later than 30 April 2008, the Commission shall present a report to the European Parliament and the Council concerning the application of this provision with a view to proposing any necessary amendments.

  • The Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005156Law

    … 6 to those Regulations” insert “or an authorization granted by the licensing authority in accordance with Article 126a of Directive 2001/83/EC”.

  • Directive (EU) 2022/642Law

    … Kypru a Malty z důvodů ochrany veřejného zdraví a na určitou dobu povoleno udělit registrace na základě článku 126a směrnice 2001/83/ES, které se opírají o registrace udělené příslušnými orgány jiných částí …

  • Regulation (EU) 2024/5681Law

    … Na humánní léčivé přípravky, které jsou registrovány k uvedení na trh v souladu s článkem 126a směrnice 2001/83/ES, se nevztahují poplatky za farmakovigilanční činnosti stanovené v přílohách tohoto nařízení.

  • Opinion of Advocate General Jääskinen delivered on 29 September 2011. European Commission v Republic of Poland.Decision

    There are two exceptions to this general rule. A Member State may derogate from Article 6 provided that the special needs requirement is fulfilled (Article 5 of Directive 2001/83), or if it is necessary for public health reasons (Article …

    29 Sep 2011 · 62010CC0185

  • Opinion of Advocate General Sharpston delivered on 30 May 2013. Laboratoires Lyocentre v Lääkealan turvallisuus- ja kehittämiskeskus and SosDecision

    If such a product is immediately removed from the market following a decision of the competent authority pursuant to Article 18 of the Medical Devices Directive, then there is no need for further Member State action under Article 18, first …

    30 May 2013 · 62012CC0109

  • Opinion of Advocate General Jääskinen delivered on 7 November 2013. Octapharma France SAS v Agence nationale de sécurité du médicament et deDecision

    In the case to hand, there is a dearth of concrete information concerning, inter alia, the practical effects of the three month time limit for the adoption of a new decision by the Director General of AFSSAPS (now ANSM) and for the …

    7 Nov 2013 · 62012CC0512